🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase III study is designed to evaluate the efficacy and safety of KX2...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-09-18
Trial ID
NCT03285477
Treatments Being Tested
In this study, the activity, safety, and pharmacokinetics (PK) of KX2-391 O...
Status
Completed
Location
Center for Dermatology Clinical Research
Start Date
2016-04-11
Trial ID
NCT02838628
Treatments Being Tested
This Phase III study was designed to evaluate the efficacy and safety of KX...
Status
Completed
Location
Alliance Dermatology
Start Date
2017-09-15
Trial ID
NCT03285490
Treatments Being Tested
The standard of care for patients with bone-metastatic, castrate-resistant ...
Status
Completed
Location
University of Chicago
Start Date
2010-02
Trial ID
NCT01074138
Treatments Being Tested
This Phase I study is designed to evaluate the systemic exposure and safety...
Status
Completed
Location
TKL Research
Start Date
2018-09-07
Trial ID
NCT03575780
Treatments Being Tested
This Phase 1b study will determine the maximum tolerated dose of KX2-391 gi...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-12
Trial ID
NCT01397799
Treatments Being Tested
This is a phase 1 study to access the safety and tolerability of KX2-391 oi...
Status
Completed
Location
DermResearch, Inc.
Start Date
2014-12
Trial ID
NCT02337205
Treatments Being Tested
RATIONALE: KX2-391 may stop the growth of cancer cells by blocking some of ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2007-10
Trial ID
NCT00646139
Treatments Being Tested
The purpose of this Phase 1 study is to determine the safety and tolerabili...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2007-11
Trial ID
NCT00658970
Treatments Being Tested
The primary objective of this study is to determine the maximum tolerated d...
Status
Unknown
Location
Seoul National University Bundang Hospital
Start Date
2012-12
Trial ID
NCT01764087
Treatments Being Tested